The Big Hurt: Second Major Fibromyalgia Drug in a Year Fails

It wasn’t supposed to go this way. ┬áDaiichi Sankyo bet big, big money that it’s safer, more effective version of Lyrica (pregabalin) called mirogabalin was going to be the next big thing in fibromaylgia (FM). It was so confident that it embarked on a global series of trials involving over … Continue reading The Big Hurt: Second Major Fibromyalgia Drug in a Year Fails